Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST).
Published in: American Heart Journal
Date of publication: July 1, 1999
Language: English
Main subject: heart failure, patient
Bibliographic databases:
Cites articles 19
- October 1, 1996
Date
Title
Article -